Events

presented by Dr Nadine Ezard.

We conducted a randomised double-blind placebo controlled trial of 250mg lisdexamfetamine daily vs placebo among 164 adults with methamphetamine dependence at 6 outpatient services around Australia.

presented by Benn Veenker

This presentation will start with unpacking exactly what is lived and living experience and what does this mean within an AOD context.

presented by Clare Slattery, Legal Policy Advisor at the McCabe Centre for Law and Cancer

Alcohol use is linked to more than 200 diseases, injuries and other health conditions, including cancer.

presented by Dr Tanya Saraiya

Up to 90% of people with opioid use disorder (OUD) have trauma exposure and up to 41% have posttraumatic stress disorder (PTSD).

presented by Georgia Bolt

This presentation situates cognitive impairment as a key factor to be considered within the AOD sector.

presented by Turning Point

Discover the diverse array of study opportunities at Turning Point in addiction sciences, featuring internships, scholarships, post-graduate courses, and PhD projects.

presented by Dr Bosco Rowland.

Originating in the US, Communities that Care is a public health prevention framework that has been operating in Australia for 25 years.

presented by Julaine Allan & Jacqui Cameron

Nitrous Oxide (N2O), colloquially known as “laughing gas” or “nangs”, is a dissociative anaesthetic that has become increasingly popular among young people.

presented by Professor Billie Bonevski

E-cigarettes containing nicotine (e-cigarettes) have demonstrated effectiveness for smoking cessation among general populations, but limited evidence in people with substance use disorders (SUD).